Updated
Reviewed
Aug. 01, 2019
Appendix B: Panel Roster and Financial Disclosures
Herpes (HSV/VZV)
| Member | Financial Disclosure | ||
|---|---|---|---|
| Company | Relationship | ||
| Durand, Christine | Johns Hopkins | AbbVie | Research Support |
| Gilead | Grant Review Committee | ||
| ViiV Healthcare | Research Support | ||
| Gnann, John | Medical University of South Carolina | BioCryst | Data and Safety Monitoring Board Member |
| GlaxoSmithKline | Data and Safety Monitoring Board Member | ||
| Holland, Gary | University of California, Los Angeles | None | N/A |
| Johnston, Christine | University of Washington | Sanofi-Pasteur | Research Support |
| UpToDate | Royalties | ||
| Parsons, Christopher | Pardee Hospital, University of North Carolina Health Systems | None | N/A |
| Phipps, Warren | University of Washington School of Medicine | None | N/A |
| Ross, Shannon | University of Alabama at Birmingham | Children’s Hospital of Alabama Kaul Pediatric Research Institute | Research Support |
| Merck | Advisory Board | ||
| Meridian Bioscience | Educational Webinar | ||
| Roche | Advisory Board | ||
| Van Wagoner, Nicholas* | University of Alabama at Birmingham | Genocea | Research Support |
| Sanofi-Pasteur | Research Support | ||
| Wohl, David | University of North Carolina at Chapel Hill | Gilead | Research Support, Consultant, Speaking Compensation |
| Janssen | Speaking Compensation | ||
| Merck | Research Support, Speaking Compensation | ||
| ViiV Healthcare | Research Support, Speaking Compensation | ||
| *Group lead Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019. |
|||
Download Guidelines
- Section OnlyPDF (337.79 KB)
- Full GuidelinePDF (3.78 MB)
- Tables OnlyPDF (481.21 KB)